Ex-Glaxo Lawyer ‘Went Too Far,’ U.S. Says at Trial’s Opening

An ex-GlaxoSmithKline Plc attorney accused of covering up the company’s improper marketing of its antidepressant drug Wellbutrin SR is a “lawyer who went too far,” a federal prosecutor said as her trial began.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.